Drug intelligence / Profile preview

Weihrauch

Development stage
Unknown
Lead developer
MCM Klosterfrau
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Weihrauch (frankincense), specifically derived from the gum resin of the *Boswellia serrata* tree, is a traditional botanical extract widely used for its anti-inflammatory and joint-supporting properties. Marketed by MCM Klosterfrau under the brand name Gelenke Weihrauch, it is formulated as an oral dietary supplement to help maintain joint flexibility and support the overall health of the musculoskeletal system. The active components of Weihrauch, primarily boswellic acids, are believed to inhibit inflammatory pathways, such as the 5-lipoxygenase (5-LOX) enzyme, thereby reducing joint discomfort and stiffness associated with physical exertion, wear, or aging.

Brand names
AflapinBoswellia-LogesGelenke WeihrauchKlosterfrau Gelenke WeihrauchWeihrauch 85% Boswellia Plus
Other names
Boswellia serrataBoswellia serrata extractIndian frankincenseOlibanumfrankincenseindischer Weihrauch
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Weihrauch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weihrauch.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call